Best time to assess complete clinical response after chemoradiotherapy in squamous cell carcinoma of the anus (ACT II): a post-hoc analysis of randomised controlled phase 3 trial

Flam, 1996, Role of mitomycin in combination with fluorouracil and radiotherapy and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup study, J Clin Oncol, 14, 2527, 10.1200/JCO.1996.14.9.2527 1996, UKCCCR Anal Cancer Working Party: epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil and mitomycin, Lancet, 348, 1049, 10.1016/S0140-6736(96)03409-5 Bartelink, 1997, J Clin Oncol, 15, 2040, 10.1200/JCO.1997.15.5.2040 Northover, 2010, Chemoradiation for the treatment of epidermoid anal cancer: 13-year follow-up of the first randomised UKCCCR Anal Cancer Trial (ACT I), Br J Cancer, 102, 1123, 10.1038/sj.bjc.6605605 Ajani, 2008, Fluorouracil, mitomycin and radiotherapy vs fluorouracil, cisplatin and radiotherapy for carcinoma of the anal canal: a randomised controlled trial, JAMA, 199, 1914, 10.1001/jama.299.16.1914 Peiffert, 2012, Induction chemotherapy and dose intensification of the radiation boost in locally advanced anal canal carcinoma: final analysis of the randomized UNICANCER ACCORD 03 trial, J Clin Oncol, 30, 1941, 10.1200/JCO.2011.35.4837 James, 2013, Mitomycin or cisplatin chemoradiation with or without maintenance chemotherapy for treatment of squamous-cell carcinoma of the nus (ACT II): a randomised, phase 3, open-label, 2×2 factorial trial, Lancet Oncol, 14, 516, 10.1016/S1470-2045(13)70086-X Glynne-Jones, 2014, Anal cancer: ESMO-ESSO-ESTRO clinical practice guidelines for diagnosis, treatment and follow-up, Ann Oncol, 25, iii10, 10.1093/annonc/mdu159 Hong, 2014, Expert Panel on Radiation Oncology–Rectal/Anal Cancer, ACR appropriateness criteria-anal cancer, Gastrointest Cancer Res, 7, 4 2016, National Comprehensive Cancer Network (NCCN) Clinical Practice guidelines in Oncology, Anal Carcinoma Bentzen, 2012, Chemoradiotherapy of anal carcinoma: survival and recurrence in an unselected national cohort, Int J Radiation Oncol Biol Phys, 83, e173, 10.1016/j.ijrobp.2011.12.062 Spiessl, 1989 Salani, 2011, Posttreatment surveillance and diagnosis of recurrence in women with gynecologic malignancies: Society of Gynecologic Oncologists recommendations, Am J Obstet Gynecol, 204, 466, 10.1016/j.ajog.2011.03.008 Theresse, 2000, New guidelines to evaluate the response to treatment in solid tumours, J Nat Cancer Inst, 92, 205, 10.1093/jnci/92.3.205 Cummings, 1991, Epidermoid anal cancer: treatment by radiation alone or by radiation and 5-fluorouracil with and without mitomycin C, Int J Radiat Oncol Biol Phys, 21, 1115, 10.1016/0360-3016(91)90265-6 Derniaud-Alexandre, 2003, Results of definitive irradiation in a series of 305 epidermoid carcinomas of the anal canal, Int J Radiation Oncol Biol Phys, 56, 1259, 10.1016/S0360-3016(03)00417-6 Chapet, 2005, Prognostic value of tumor regression evaluated after first course of radiotherapy for anal canal cancer, Int J Radiat Oncol Biol Phys, 63, 1316, 10.1016/j.ijrobp.2005.05.047 Gerard, 1998, Treatment of anal canal carcinoma with high dose radiation therapy and concomitant fluorouracil-cisplatinum. Long-term results in 95 patients, Radiother Oncol, 46, 249, 10.1016/S0167-8140(97)00192-8 Tanum, 1993, Chemoradiotherapy of anal carcinoma: tumour response and acute toxicity, Oncology, 50, 14, 10.1159/000227140 Borzomati, 2005, Persisting anal ulcer after radiotherapy for anal cancer: recurrence of disease or late radiation-related complication?, Hepatogastroenterology, 52, 780 Wolff, 2011, High-grade acute organ toxicity as a positive prognostic factor in primary radiochemotherapy for anal carcinoma, Int J Radiat Oncol Biol Phys, 79, 1467, 10.1016/j.ijrobp.2010.01.010 Parikh, 2011, Anal carcinomas: the role of endoanal ultrasound and magnetic resonance imaging in staging, response evaluation and follow-up, Eur Radiol, 21, 776, 10.1007/s00330-010-1980-7 Giovannini, 2001, Anal carcinoma: prognostic value of endorectal ultrasound (ERUS). Results of a prospective multicenter study, Endoscopy, 33, 231, 10.1055/s-2001-12860 Goh, 2010, Magnetic resonance imaging assessment of squamous cell carcinoma of the anal canal before and after chemoradiation: can MRI predict for eventual clinical outcome?, Int J Radiat Oncol Biol Phys, 78, 715, 10.1016/j.ijrobp.2009.08.055 Trautmann, 2005, Positron emission tomography for pre-treatment staging and postreatment evaluation in cancer of the anal canal, Mol Imaging Biol, 7, 309, 10.1007/s11307-005-0003-6 Schwarz, 2008, Tumor response and survival predicted by post-therapy FDG-PET/CT in anal cancer, Int J Radiat Oncol Biol Phys, 71, 180, 10.1016/j.ijrobp.2007.09.005 Mistrangelo, 2012, Role of positron emission tomography-computed tomography in the management of anal cancer, Int J Radiat Oncol Biol Phys, 84, 66, 10.1016/j.ijrobp.2011.10.048 Nilsson, 2002, Salvage abdominoperineal resection in anal epidermoid cancer, Br J Surg, 89, 1425, 10.1046/j.1365-2168.2002.02231.x Mullen, 2007, Results of surgical salvage after failed chemoradiation therapy for epidermoid carcinoma of the anal canal, Ann Surg Oncol, 14, 478, 10.1245/s10434-006-9221-7 Fleshner, 2008, Standards practice task force: American Society of Colon and Rectal Surgeons. Practice perimeters for anal squamous neoplasms, Dis Colon Rectum, 51, 2, 10.1007/s10350-007-9093-3 Zampino, 2011, Concurrent cisplatin, continuous infusion fluorouracil and radiotherapy followed by tailored consolidation treatment in non metastatic anal squamous cell carcinoma, BMC Cancer, 11, 55, 10.1186/1471-2407-11-55